Jena, Germany

Nico Braeuer

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nico Braeuer

Introduction

Nico Braeuer is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic applications. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Nico Braeuer holds a patent for a compound titled "8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes." This invention relates to compounds that exhibit ERβ-antagonistic activity. The general formula of these compounds allows for their production and use in pharmaceutical preparations. Notably, these new compounds can be utilized for contraception in both men and women without affecting other estrogen-sensitive organs, such as the uterus or liver. Additionally, they are suitable for treating benign or malignant proliferative diseases of the ovary, including ovarian cancer and granulosa cell tumors. Braeuer's patent represents a significant advancement in the field of reproductive health and oncology.

Career Highlights

Nico Braeuer is associated with Schering Aktiengesellschaft, a company known for its focus on innovative pharmaceutical solutions. His work at the company has allowed him to contribute to the development of groundbreaking medical treatments. With a total of 1 patent, Braeuer's contributions are recognized within the scientific community.

Collaborations

Throughout his career, Nico Braeuer has collaborated with esteemed colleagues, including Olaf Peters and Alexander Hillisch. These collaborations have fostered an environment of innovation and have led to the advancement of various projects within the pharmaceutical sector.

Conclusion

Nico Braeuer's innovative work in the field of pharmaceuticals highlights his commitment to improving health outcomes through scientific research. His patent for 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes showcases his ability to develop compounds with significant therapeutic potential. His contributions are paving the way for future advancements in reproductive health and oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…